Pages that link to "Q35117549"
Jump to navigation
Jump to search
The following pages link to Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma (Q35117549):
Displaying 50 items.
- Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal (Q26744536) (← links)
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks (Q26752554) (← links)
- Promising Therapy Candidates for Liver Fibrosis (Q26766727) (← links)
- Immune checkpoint inhibitors: therapeutic advances in melanoma (Q26775591) (← links)
- Other targeted drugs in melanoma (Q26775594) (← links)
- In vitro cancer cell-ECM interactions inform in vivo cancer treatment (Q26781263) (← links)
- Epithelial to Mesenchymal Transition in a Clinical Perspective (Q26783554) (← links)
- Antibody-based immunotherapy of solid cancers: progress and possibilities (Q26796542) (← links)
- Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway (Q26797238) (← links)
- Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications (Q26996518) (← links)
- Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer (Q27331671) (← links)
- TGFΒ-induced transcription in cancer (Q28075605) (← links)
- TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression (Q28076815) (← links)
- Integrin β1 activation induces an anti-melanoma host response (Q33610627) (← links)
- Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta. (Q33721793) (← links)
- Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia (Q33722426) (← links)
- The platelet: sensing shear and the endocrine regulation of cardiovascular sclerosis. (Q34081200) (← links)
- Transforming growth factor-β (TGF-β) expression is increased in the subsynovial connective tissue in a rabbit model of carpal tunnel syndrome (Q34277194) (← links)
- Microbiota modulation of myeloid cells in cancer therapy (Q35073092) (← links)
- Advances in phage display technology for drug discovery (Q35614190) (← links)
- Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms. (Q35840270) (← links)
- Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients (Q36040200) (← links)
- TGF-β1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT) (Q36121570) (← links)
- Evolution of phage display technology: from discovery to application. (Q36183954) (← links)
- Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation. (Q36758301) (← links)
- Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy (Q37079141) (← links)
- Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer? (Q37219226) (← links)
- Trial Watch: Immunotherapy plus radiation therapy for oncological indications (Q37308207) (← links)
- Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma (Q37687730) (← links)
- Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology. (Q38241160) (← links)
- Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008). (Q38314581) (← links)
- Republished: Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology (Q38481540) (← links)
- Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases (Q38500621) (← links)
- New therapies for hepatic fibrosis (Q38553309) (← links)
- Immune-mediated pathology in Duchenne muscular dystrophy (Q38561435) (← links)
- Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics. (Q38563910) (← links)
- Natural killer cell receptors: alterations and therapeutic targeting in malignancies (Q38587627) (← links)
- Matters of context guide future research in TGFβ superfamily signaling (Q38612468) (← links)
- Cancer Immunotherapy: Historical Perspective of a Clinical Revolution and Emerging Preclinical Animal Models (Q38616707) (← links)
- Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells (Q38661469) (← links)
- Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy. (Q38714700) (← links)
- Drug Development for Metastasis Prevention (Q38859710) (← links)
- New Developments on the Treatment of Liver Fibrosis (Q38873303) (← links)
- Autophagy: controlling cell fate in rheumatic diseases (Q38873681) (← links)
- The evolving role of monoclonal antibodies in the treatment of patients with advanced renal cell carcinoma: a systematic review. (Q38910154) (← links)
- Approaches for targeting cancer stem cells drug resistance (Q38971795) (← links)
- Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer (Q38988997) (← links)
- Pharmacological and immunological targeting of tumor mesenchymalization (Q39029043) (← links)
- The role of the immune system in neurofibromatosis type 1-associated nervous system tumors (Q39045958) (← links)
- Liver inflammation and fibrosis (Q39065620) (← links)